News & events
Press Releases
On the 28th March 2022, OncoArendi changed its name to Molecure
OncoArendi Therapeutics has entered into a global license agreement with Yale University
10 February 2015
OncoArendi receives a grant of over 7 mln PLN for its lead drug discovery program
14 July 2014
On June 2, 2014 OncoArendi received another grant for IP protection PL
2 June 2014